Sun Pharmaceutical Industries Limited Company Profile and News

NSE : SUNPHARMA BSE : 524715 ISIN CODE : INE044A01036 Industry : Pharmaceuticals & Drugs House : Sun Pharma

 

Related News: 

Sun Pharmaceutical: Buy, sell or hold? What should investors do after Q2 results?

Sun Pharma Ltd rises to record on key drug settlement

 

Company Overview:

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances, as well as over-the-counter products. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India.
Industry: Drug ManufacturersSpecialty & Generic
Sector: Healthcare
Phone: 91 22 4324 4324

 

Management:

Chairman Israel Makov
Managing Director Dilip S Shanghvi
Company Secretary Sunil R Ajmera
Non Executive Independent Director Rekha Sethi
Vivek Chaand Sehgal
Gautam Doshi
Pawan Goenka
Rama Bijapurkar
Whole Time Director Sailesh T Desai
Kalyanasundaram Subramanian
Non Independent & Non Executive Director Sudhir V Valia